References
- Murtaza M , DawsonSJ, TsuiDWet al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497, 108 – 112 (2013).
- Goldhirsch A , GelberRD, Piccart-GebhartMJet al. 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial. Lancet 382 (9897), 1021 – 1028 (2013).
- Gerlinger M , RowanNJ, HorswellSet al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366 (10), 883 – 892 (2012).
- Aparicio S , CaldasC. The implications of clonal genome evolution for cancer medicine.N. Engl. J. Med.368, 842 – 851 (2013).
- Klein CA . Selection and adaptation during metastatic cancer progression.Nature501 (7467), 365 – 372 (2013).
- Bedard PL , HansenAR, RatainMJ, SiuLLet al. Tumour heterogeneity in the clinic. Nature 501, 355 – 364 (2013).
- Nowell PC . The clonal evolution of tumor cell populations.Science194, 23 – 28 (1976).
- Pantel K , DiazLAJr, PolyakK. Tracking tumor resistance using ‘liquid biopsies’.Nat. Med.19 (6), 676 – 677 (2013).
- Fan HC , GuW, WangJ, BlumenfeldYJ, El-SayedYY, QuakeSR. Non-invasive prenatal measurement of the fetal genome.Nature487, 320 – 324 (2012).
- The Rosenfeld Lab: noninvasive cancer diagnostics . www.rosenfeldlab.org
- Chan KC , JiangP, ZhengYWet al. Cancer genome scanning in plasma: detection of tumorassociated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin. Chem. 59, 211 – 224 (2013).
- Leary RJ , SausenM, KindeIet al. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci. Transl. Med. 4, 162 (2012).
- Leary RJ , SausenM, DiazLAJr, VelculescuVE. Cancer detection using whole-genome sequencing of cell free DNA.Oncotarget4 (8), 1119 – 1120 (2013).
- Bettegowda C , SausenM, LearyRJet al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl. Med. 6 (224), 224ra24 (2014).
- The Cancer Genome Atlas – National Cancer Institute . http://cancergenome.nih.gov
- International Cancer Genome Consortium . http://icgc.org
- Lawrence MS , StojanovP, MermelCHet al. Discovery and saturation analysis of cancer genes across 21 tumor types. Nature 505 (7484), 495 – 501 (2014).
- Gerstein MB , KundajeA, HariharanMet al. Architecture of the human regulatory network derived from ENCODE data. Nature 489 (7414), 91 – 100 (2012).
- Neph S , StergachisAB, ReynoldsA, SandstromR, BorensteinE, StamatoyannopoulosJA. Circuitry and dynamics of human transcription factor regulatory networks.Cell150 (6), 1274 – 1286 (2012).
- ENCODE Project Consortium . An integrated encyclopedia of DNA elements in the human genome.Nature489 (7414), 57 – 74 (2012).
- Sanyal A , LajoieB, JainG, DekkerJ. The long-range interaction landscape of gene promoters.Nature489 (7414), 109 – 113 (2012).
- Yosef N , ShalekAK, GaublommeJTet al. Dynamic regulatory network controlling Th17 cell differentiation. Nature 496 (7446), 461 – 468 (2013).
- Cheng TM , GulatiS, AgiusR, BatesPA. Understanding cancer mechanisms through network dynamics.Brief Funct. Genomics11 (6), 543 – 560 (2012).